Delek Group’s AB InBev BUD Stock Holding History

Delek Group’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-120	Closed	-$13K	–	245
2017 Q4	$13K	Buy	+120	New	+$14.1K	﹤0.01%	293

Other funds holding BUD

SCP

Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Delek Group's BUD Position: Q1 2018 in Review

Delek Group sold out of AB InBev (BUD) in Q1 2018, closing a stake of 120 shares — an estimated $13K sold.

Delek Group first reported a position in BUD in Q4 2017 and held it in 1 quarter. The position peaked at $13K in Q4 2017. 587 funds tracked by Wall St. Rank hold BUD as of Q1 2018.

Delek Group reported no remaining AB InBev position as of Q1 2018 after selling out during the quarter.
Delek Group sold 120 AB InBev shares in Q1 2018, an estimated $13K.
Delek Group first reported a position in AB InBev in Q4 2017 and held it in 1 quarter.
Delek Group's AB InBev position peaked at $13K in Q4 2017.
587 funds tracked by Wall St. Rank held AB InBev as of Q1 2018.

Based on Delek Group's 13F filing for Q1 2018, filed 15 May 2018.